Loading…

Understanding osteomyelitis and its treatment through local drug delivery system

Chronic osteomyelitis is a major challenge in bone surgery. Conventional use of antibiotics is not an effective way to control the malaise due to so many reasons. Determination of optimal treatment strategy becomes difficult for the orthopaedic surgeons and as a consequence, the patients suffer not...

Full description

Saved in:

Bibliographic Details
Published in:	Biotechnology advances 2016-12, Vol.34 (8), p.1305-1317
Main Authors:	Nandi, Samit Kumar, Bandyopadhyay, Samiran, Das, Piyali, Samanta, Indranil, Mukherjee, Prasenjit, Roy, Subhasis, Kundu, Biswanath
Format:	Article
Language:	English
Subjects:	Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antibiotics Biocompatibility Biocompatible Materials Biomedical materials Bone diseases Bones Chromium Drug Delivery Systems Etiology Experiments Failure Humans Osteomyelitis - drug therapy Osteomyelitis - epidemiology Osteomyelitis - physiopathology Risk Factors Side effects Toxicity
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by
cites
container_end_page	1317
container_issue	8
container_start_page	1305
container_title	Biotechnology advances
container_volume	34
creator	Nandi, Samit Kumar Bandyopadhyay, Samiran Das, Piyali Samanta, Indranil Mukherjee, Prasenjit Roy, Subhasis Kundu, Biswanath
description	Chronic osteomyelitis is a major challenge in bone surgery. Conventional use of antibiotics is not an effective way to control the malaise due to so many reasons. Determination of optimal treatment strategy becomes difficult for the orthopaedic surgeons and as a consequence, the patients suffer not only from therapeutic failure but also due to adverse side effects of antibiotics and financial loss due to additional stay at hospitals. A wide application of carrier systems, as a medium for local delivery of antibiotics, is being used experimentally and clinically for the treatment of osteomyelitis. This kind of delivery system provides sustained higher concentration of antibiotics at the infection site with reduced possibility of toxicity. This review highlight etiology and pathophysiology of osteomyelitis, current therapeutic options with their limitations, and potentiality of biomaterial based carrier materials impregnated with antibiotics as local delivery approach.
doi_str_mv	10.1016/j.biotechadv.2016.09.005
format	article
fullrecord	<record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_1864531241</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1850775180</sourcerecordid><originalsourceid>FETCH-LOGICAL-p305t-78f2ce48a923e8127e43c8a70300ee80eb584575d706de4f57fdb0e5ad1a9ef13</originalsourceid><addsrcrecordid>eNqN0E1LAzEQBuAgiq3VvyABL152nSSbTXKU4hcU9GDPS7qZbbfsR02yhf33LlgvnjwNvDzvwAwhlEHKgOUP-3RT9xHLnXXHlE9JCiYFkGdkzrQSCdPGnJM5KJElRkmYkasQ9gBMghSXZMZVboRiak4-1p1DH6LtXN1taR8i9u2ITR3rQKeQ1jHQ6NHGFrtI4873w3ZHm760DXV-2FI34SP6kYZxKrfX5KKyTcCb01yQ9fPT5_I1Wb2_vC0fV8lBgIyJ0hUvMdPWcIGacYWZKLVVIAAQNeBG6kwq6RTkDrNKqsptAKV1zBqsmFiQ-5-9B99_DRhi0dahxKaxHfZDKJjOMykYz_5DJSglmYaJ3v2h-37w3XRIwYEzo_NcyEndntSwadEVB1-31o_F71vFN-m3fV4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2021986635</pqid></control><display><type>article</type><title>Understanding osteomyelitis and its treatment through local drug delivery system</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Nandi, Samit Kumar ; Bandyopadhyay, Samiran ; Das, Piyali ; Samanta, Indranil ; Mukherjee, Prasenjit ; Roy, Subhasis ; Kundu, Biswanath</creator><creatorcontrib>Nandi, Samit Kumar ; Bandyopadhyay, Samiran ; Das, Piyali ; Samanta, Indranil ; Mukherjee, Prasenjit ; Roy, Subhasis ; Kundu, Biswanath</creatorcontrib><description>Chronic osteomyelitis is a major challenge in bone surgery. Conventional use of antibiotics is not an effective way to control the malaise due to so many reasons. Determination of optimal treatment strategy becomes difficult for the orthopaedic surgeons and as a consequence, the patients suffer not only from therapeutic failure but also due to adverse side effects of antibiotics and financial loss due to additional stay at hospitals. A wide application of carrier systems, as a medium for local delivery of antibiotics, is being used experimentally and clinically for the treatment of osteomyelitis. This kind of delivery system provides sustained higher concentration of antibiotics at the infection site with reduced possibility of toxicity. This review highlight etiology and pathophysiology of osteomyelitis, current therapeutic options with their limitations, and potentiality of biomaterial based carrier materials impregnated with antibiotics as local delivery approach.</description><identifier>ISSN: 0734-9750</identifier><identifier>EISSN: 1873-1899</identifier><identifier>DOI: 10.1016/j.biotechadv.2016.09.005</identifier><identifier>PMID: 27693717</identifier><language>eng</language><publisher>England: Elsevier Science Ltd</publisher><subject>Anti-Bacterial Agents - administration & dosage ; Anti-Bacterial Agents - therapeutic use ; Antibiotics ; Biocompatibility ; Biocompatible Materials ; Biomedical materials ; Bone diseases ; Bones ; Chromium ; Drug Delivery Systems ; Etiology ; Experiments ; Failure ; Humans ; Osteomyelitis - drug therapy ; Osteomyelitis - epidemiology ; Osteomyelitis - physiopathology ; Risk Factors ; Side effects ; Toxicity</subject><ispartof>Biotechnology advances, 2016-12, Vol.34 (8), p.1305-1317</ispartof><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. Dec 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27693717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nandi, Samit Kumar</creatorcontrib><creatorcontrib>Bandyopadhyay, Samiran</creatorcontrib><creatorcontrib>Das, Piyali</creatorcontrib><creatorcontrib>Samanta, Indranil</creatorcontrib><creatorcontrib>Mukherjee, Prasenjit</creatorcontrib><creatorcontrib>Roy, Subhasis</creatorcontrib><creatorcontrib>Kundu, Biswanath</creatorcontrib><title>Understanding osteomyelitis and its treatment through local drug delivery system</title><title>Biotechnology advances</title><addtitle>Biotechnol Adv</addtitle><description>Chronic osteomyelitis is a major challenge in bone surgery. Conventional use of antibiotics is not an effective way to control the malaise due to so many reasons. Determination of optimal treatment strategy becomes difficult for the orthopaedic surgeons and as a consequence, the patients suffer not only from therapeutic failure but also due to adverse side effects of antibiotics and financial loss due to additional stay at hospitals. A wide application of carrier systems, as a medium for local delivery of antibiotics, is being used experimentally and clinically for the treatment of osteomyelitis. This kind of delivery system provides sustained higher concentration of antibiotics at the infection site with reduced possibility of toxicity. This review highlight etiology and pathophysiology of osteomyelitis, current therapeutic options with their limitations, and potentiality of biomaterial based carrier materials impregnated with antibiotics as local delivery approach.</description><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibiotics</subject><subject>Biocompatibility</subject><subject>Biocompatible Materials</subject><subject>Biomedical materials</subject><subject>Bone diseases</subject><subject>Bones</subject><subject>Chromium</subject><subject>Drug Delivery Systems</subject><subject>Etiology</subject><subject>Experiments</subject><subject>Failure</subject><subject>Humans</subject><subject>Osteomyelitis - drug therapy</subject><subject>Osteomyelitis - epidemiology</subject><subject>Osteomyelitis - physiopathology</subject><subject>Risk Factors</subject><subject>Side effects</subject><subject>Toxicity</subject><issn>0734-9750</issn><issn>1873-1899</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqN0E1LAzEQBuAgiq3VvyABL152nSSbTXKU4hcU9GDPS7qZbbfsR02yhf33LlgvnjwNvDzvwAwhlEHKgOUP-3RT9xHLnXXHlE9JCiYFkGdkzrQSCdPGnJM5KJElRkmYkasQ9gBMghSXZMZVboRiak4-1p1DH6LtXN1taR8i9u2ITR3rQKeQ1jHQ6NHGFrtI4873w3ZHm760DXV-2FI34SP6kYZxKrfX5KKyTcCb01yQ9fPT5_I1Wb2_vC0fV8lBgIyJ0hUvMdPWcIGacYWZKLVVIAAQNeBG6kwq6RTkDrNKqsptAKV1zBqsmFiQ-5-9B99_DRhi0dahxKaxHfZDKJjOMykYz_5DJSglmYaJ3v2h-37w3XRIwYEzo_NcyEndntSwadEVB1-31o_F71vFN-m3fV4</recordid><startdate>201612</startdate><enddate>201612</enddate><creator>Nandi, Samit Kumar</creator><creator>Bandyopadhyay, Samiran</creator><creator>Das, Piyali</creator><creator>Samanta, Indranil</creator><creator>Mukherjee, Prasenjit</creator><creator>Roy, Subhasis</creator><creator>Kundu, Biswanath</creator><general>Elsevier Science Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QQ</scope><scope>7SE</scope><scope>7TA</scope><scope>7TB</scope><scope>8FD</scope><scope>FR3</scope><scope>H8G</scope><scope>JG9</scope><scope>7QO</scope><scope>P64</scope><scope>7U5</scope><scope>L7M</scope></search><sort><creationdate>201612</creationdate><title>Understanding osteomyelitis and its treatment through local drug delivery system</title><author>Nandi, Samit Kumar ; Bandyopadhyay, Samiran ; Das, Piyali ; Samanta, Indranil ; Mukherjee, Prasenjit ; Roy, Subhasis ; Kundu, Biswanath</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p305t-78f2ce48a923e8127e43c8a70300ee80eb584575d706de4f57fdb0e5ad1a9ef13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibiotics</topic><topic>Biocompatibility</topic><topic>Biocompatible Materials</topic><topic>Biomedical materials</topic><topic>Bone diseases</topic><topic>Bones</topic><topic>Chromium</topic><topic>Drug Delivery Systems</topic><topic>Etiology</topic><topic>Experiments</topic><topic>Failure</topic><topic>Humans</topic><topic>Osteomyelitis - drug therapy</topic><topic>Osteomyelitis - epidemiology</topic><topic>Osteomyelitis - physiopathology</topic><topic>Risk Factors</topic><topic>Side effects</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nandi, Samit Kumar</creatorcontrib><creatorcontrib>Bandyopadhyay, Samiran</creatorcontrib><creatorcontrib>Das, Piyali</creatorcontrib><creatorcontrib>Samanta, Indranil</creatorcontrib><creatorcontrib>Mukherjee, Prasenjit</creatorcontrib><creatorcontrib>Roy, Subhasis</creatorcontrib><creatorcontrib>Kundu, Biswanath</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Ceramic Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical & Transportation Engineering Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Copper Technical Reference Library</collection><collection>Materials Research Database</collection><collection>Biotechnology Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Biotechnology advances</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nandi, Samit Kumar</au><au>Bandyopadhyay, Samiran</au><au>Das, Piyali</au><au>Samanta, Indranil</au><au>Mukherjee, Prasenjit</au><au>Roy, Subhasis</au><au>Kundu, Biswanath</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Understanding osteomyelitis and its treatment through local drug delivery system</atitle><jtitle>Biotechnology advances</jtitle><addtitle>Biotechnol Adv</addtitle><date>2016-12</date><risdate>2016</risdate><volume>34</volume><issue>8</issue><spage>1305</spage><epage>1317</epage><pages>1305-1317</pages><issn>0734-9750</issn><eissn>1873-1899</eissn><abstract>Chronic osteomyelitis is a major challenge in bone surgery. Conventional use of antibiotics is not an effective way to control the malaise due to so many reasons. Determination of optimal treatment strategy becomes difficult for the orthopaedic surgeons and as a consequence, the patients suffer not only from therapeutic failure but also due to adverse side effects of antibiotics and financial loss due to additional stay at hospitals. A wide application of carrier systems, as a medium for local delivery of antibiotics, is being used experimentally and clinically for the treatment of osteomyelitis. This kind of delivery system provides sustained higher concentration of antibiotics at the infection site with reduced possibility of toxicity. This review highlight etiology and pathophysiology of osteomyelitis, current therapeutic options with their limitations, and potentiality of biomaterial based carrier materials impregnated with antibiotics as local delivery approach.</abstract><cop>England</cop><pub>Elsevier Science Ltd</pub><pmid>27693717</pmid><doi>10.1016/j.biotechadv.2016.09.005</doi><tpages>13</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 0734-9750
ispartof	Biotechnology advances, 2016-12, Vol.34 (8), p.1305-1317
issn	0734-9750 1873-1899
language	eng
recordid	cdi_proquest_miscellaneous_1864531241
source	ScienceDirect Freedom Collection 2022-2024
subjects	Anti-Bacterial Agents - administration & dosage Anti-Bacterial Agents - therapeutic use Antibiotics Biocompatibility Biocompatible Materials Biomedical materials Bone diseases Bones Chromium Drug Delivery Systems Etiology Experiments Failure Humans Osteomyelitis - drug therapy Osteomyelitis - epidemiology Osteomyelitis - physiopathology Risk Factors Side effects Toxicity
title	Understanding osteomyelitis and its treatment through local drug delivery system
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A11%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Understanding%20osteomyelitis%20and%20its%20treatment%20through%20local%20drug%20delivery%20system&rft.jtitle=Biotechnology%20advances&rft.au=Nandi,%20Samit%20Kumar&rft.date=2016-12&rft.volume=34&rft.issue=8&rft.spage=1305&rft.epage=1317&rft.pages=1305-1317&rft.issn=0734-9750&rft.eissn=1873-1899&rft_id=info:doi/10.1016/j.biotechadv.2016.09.005&rft_dat=%3Cproquest_pubme%3E1850775180%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p305t-78f2ce48a923e8127e43c8a70300ee80eb584575d706de4f57fdb0e5ad1a9ef13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2021986635&rft_id=info:pmid/27693717&rfr_iscdi=true